The brn-2 gene regulates the melanocytic phenotype and tumorigenic potential of human melanoma cells.

No abstract is available for this paper.

• Publication year

  1995

• Venue

  Oncogene

• Publication date

  1995-08-17

• Fields of study

  Biology, Medicine

• Identifiers
  PMID 7651733
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Primary brain tumors differ in their expression of octamer deoxyribonucleic acid-binding transcription factors from long-term cultured glioma cell lines.

  1994cited by this paper
• Targeted mutations in the Caenorhabditis elegans POU homeo box gene ceh-18 cause defects in oocyte cell cycle arrest, gonad migration, and epidermal differentiation.

  1994cited by this paper
• A nonconsensus octamer‐recognition sequence (TAATGARAT‐motif) identifies a novel DNA binding protein in human merkel cell carcinoma cell lines

  1994cited by this paper
• Microcell-mediated transfer of chromosome 6 into metastatic human C8161 melanoma cells suppresses metastasis but does not inhibit tumorigenicity.

  1994cited by this paper
• The distribution of cellular adhesion molecules in pigmented skin lesions

  1994cited by this paper
• The Drosophila miti-mere gene, a member of the POU family, is required for the specification of the RP2/sibling lineage during neurogenesis.

  1994cited by this paper
• Disruption of epithelial cell-matrix interactions induces apoptosis

  1994cited by this paper
• Traffic signals for lymphocyte recirculation and leukocyte emigration: the multistep paradigm.

  1994cited by this paper
• The effect of antisense inhibition of urokinase receptor in human squamous cell carcinoma on malignancy.

  1994cited by this paper
• Growth inhibition of human melanoma cells in nude mice by antisense strategies to the type 1 insulin-like growth factor receptor.

  1994cited by this paper
• Transformation by homeobox genes can be mediated by selective transcriptional repression.

  1994cited by this paper
• microphthalmia, a critical factor in melanocyte development, defines a discrete transcription factor family.

  1994cited by this paper
• Microphthalmia-associated transcription factor as a regulator for melanocyte-specific transcription of the human tyrosinase gene

  1994cited by this paper
• Expression studies of pigmentation and POU-domain genes in human melanoma cells.

  1994cited by this paper
• A POU gene required for early cleavage and protein accumulation in the sea urchin embryo.

  1994cited by this paper
• Melanocyte-specific expression of the human tyrosinase promoter: activation by the microphthalmia gene product and role of the initiator

  1994cited by this paper
• Waardenburg syndrome type 2 caused by mutations in the human microphthalmia (MITF) gene

  1994cited by this paper
• Murine chromosomal location of four class III POU transcription factors.

  1993cited by this paper
• Increased manganese superoxide dismutase expression suppresses the malignant phenotype of human melanoma cells.

  1993cited by this paper
• A CNS-specific POU transcription factor, Brn-2, is required for establishing mammalian neural cell lineages.

  1993cited by this paper
• POU domain transcription factors.

  1993cited by this paper
• Altered protein binding to the octamer motif appears to be an early event in programmed neuronal cell death.

  1993cited by this paper
• Chromosomal organization of mammalian POU domain factors.

  1993cited by this paper
• The role of a Drosophila POU homeo domain gene in the specification of neural precursor cell identity in the developing embryonic central nervous system.

  1993cited by this paper
• In vivo and in vitro expression of octamer binding proteins in human melanoma metastases, brain tissue, and fibroblasts.

  1993cited by this paper
• Modification of antisense phosphodiester oligodeoxynucleotides by a 5' cholesteryl moiety increases cellular association and improves efficacy.

  1993cited by this paper
• Spacing and orientation of bipartite DNA-binding motifs as potential functional determinants for POU domain factors.

  1993cited by this paper
• cDNA cloning of human N-Oct3, a nervous-system specific POU domain transcription factor binding to the octamer DNA motif.

  1993cited by this paper
• Mouse Brn-3 family of POU transcription factors: a new aminoterminal domain is crucial for the oncogenic activity of Brn-3a.

  1993cited by this paper
• Mutations at the mouse microphthalmia locus are associated with defects in a gene encoding a novel basic-helix-loop-helix-zipper protein.

  1993cited by this paper
• The SCID mouse: relevance as an animal model system for studying human disease.

  1993cited by this paper
• Broad binding-site specificity and affinity properties of octamer 1 and brain octamer-binding proteins.

  1993cited by this paper
• Human small cell lung cancer expresses the octamer DNA-binding and nervous system-specific transcription factor N-Oct 3 (brain-2).

  1992cited by this paper
• Mini-Oct and Oct-2c: two novel, functionally diverse murine Oct-2 gene products are differentially expressed in the CNS.

  1992cited by this paper
• Expression of a family of POU-domain protein regulatory genes during development of the central nervous system.

  1992cited by this paper
• pGSTag--a versatile bacterial expression plasmid for enzymatic labeling of recombinant proteins.

  1992cited by this paper
• Brain 4: a novel mammalian POU domain transcription factor exhibiting restricted brain‐specific expression.

  1992cited by this paper
• Structure and evolution of four POU domain genes expressed in mouse brain.

  1992cited by this paper
• Octamania: the POU factors in murine development.

  1991cited by this paper
• A melanoma octamer binding protein is responsive to differentiating agents.

  1991cited by this paper
• The SCID mouse mutant: definition, characterization, and potential uses.

  1991cited by this paper
• Cell adhesion molecules of the immunoglobulin supergene family and their role in malignant transformation and progression to metastatic disease

  1991cited by this paper
• A liver-enriched transcriptional activator protein, LAP, and a transcriptional inhibitory protein, LIP, are translated from the same mRNA.

  1991cited by this paper
• Transcription factor AP-2 is expressed in neural crest cell lineages during mouse embryogenesis.

  1991cited by this paper
• Loss of heterozygosity for loci on the long arm of chromosome 6 in human malignant melanoma.

  1991cited by this paper
• Tumorigenicity in human melanoma cell lines controlled by introduction of human chromosome 6.

  1990cited by this paper
• Dwarf locus mutants lacking three pituitary cell types result from mutations in the POU-domain gene pit-1

  1990cited by this paper
• In vitro phenotypic alteration of human melanoma cells induced by differentiating agents: heterogeneous effects on cellular growth and morphology, enzymatic activity, and antigenic expression.

  1990cited by this paper
• Reassessment of two apparent deletions of chromosome 16p to an ins(11;16) and a t(1;16) by chromosome painting.

  1990cited by this paper
• Astrocytes and glioblastoma cells express novel octamer-DNA binding proteins distinct from the ubiquitous Oct-1 and B cell type Oct-2 proteins.

  1990cited by this paper
• De novo expression of intercellular-adhesion molecule 1 in melanoma correlates with increased risk of metastasis.

  1989cited by this paper
• Identification of a recurring translocation site involving chromosome 6 in human malignant melanoma.

  1989cited by this paper
• MUC18, a marker of tumor progression in human melanoma, shows sequence similarity to the neural cell adhesion molecules of the immunoglobulin superfamily.

  1989cited by this paper
• The POU domain: a large conserved region in the mammalian pit-1, oct-1, oct-2, and Caenorhabditis elegans unc-86 gene products.

  1988cited by this paper
• The molecular genetics of embryonic pattern formation in Drosophila

  1988cited by this paper
• Karyotypic evolution in human malignant melanoma.

  1986cited by this paper
• Immunohistochemical demonstration of S 100 protein in malignant melanoma and pigmented nevus, and its diagnostic application

  1982cited by this paper

• Inhibition of BRN2 in Melanoma Reverses Anoikis Resistance and Sensitizes Cells to Killing by Vemurafenib

  2025cites this paper
• A BRN2:MYC transcriptional axis regulates interconversion between therapy-resistant and tumorigenic phenotypes in melanoma

  2025cites this paper
• Therapeutic targeting of anoikis resistance in cutaneous melanoma metastasis

  2023influential citation
• Genetic Regulation of Vertebrate Forebrain Development by Homeobox Genes

  2022cites this paper
• Anoikis Resistance in Melanoma

  2021cites this paper
• BRN2 and MITF together impact AXL expression in melanoma

  2020cites this paper
• Bidirectional interconversion between mutually exclusive tumorigenic and drug-tolerant melanoma cell phenotypes

  2020cites this paper
• Transcriptional regulators and alterations that drive melanoma initiation and progression

  2020cites this paper
• BRN2 expression increases anoikis resistance in melanoma

  2020cites this paper
• BRN2 is a non-canonical melanoma tumor-suppressor

  2019cites this paper
• METCAM/MUC18: A Novel Tumor Suppressor for Some Cancers

  2019cites this paper
• Chapter 13 Dual Role of METCAM / MUC 18 Expression in the Progression of Cancer Cells

  2019cites this paper
• DNMT1 and DNMT3B genetic polymorphisms affect the clinical course and outcome of melanoma patients.

  2019cites this paper
• The role of MITF in regulating transcriptional cell states in melanoma

  2019cites this paper
• METCAM/MUC18 Promotes Tumor Progression and Metastasis in Most Human Cancers

  2019cites this paper
• BRN2, a POUerful driver of melanoma phenotype switching and metastasis

  2018cites this paper
• Dual Role of METCAM/MUC18 Expression in the Progression of Cancer Cells

  2018cites this paper
• Altered HOX Gene Expression in Human Skin and Breast Cancer Cells

  2017cites this paper
• Modulation of Wnt/β-Catenin Signaling by Chemoprevention

  2017cites this paper
• Identification of the genetic alterations in prostate cancer metastases

  2017cites this paper
• MITF and BRN2 contribute to metastatic growth after dissemination of melanoma

  2017cites this paper
• Cancer and Chemoprevention: An Overview

  2017cites this paper
• In silico studies of the interaction between BRN2 protein and MORE DNA

  2016cites this paper
• Capsaicin Inhibited Aggressive Phenotypes through Downregulation of Tumor-Associated NADH Oxidase (tNOX) by POU Domain Transcription Factor POU3F2

  2016cites this paper
• MITF AND MELANOMA RESISTANCE TO TARGETED THERAPIES

  2016cites this paper
• Microphthalmia‐associated transcription factor in melanoma development and MAP‐kinase pathway targeted therapy

  2015cites this paper
• POU3f2 in human gliomas - Expression pattern and functional role

  2014cites this paper
• POU transcription factors in melanocytes and melanoma.

  2014cites this paper
• Regulation of MITF and Brn2 in melanoma

  2014influential citation
• Regulates Brn-2 Expression in Melanoma Pax3 Axis - A Phosphatidylinositol 3-Kinase

  2014cites this paper
• Impact of Gender in Renal Cell Carcinoma: The Relationship of FABP7 and BRN2 Expression with Overall Survival

  2014cites this paper
• POU domain transcription factor BRN2 is crucial for expression of ASCL1, ND1 and neuroendocrine marker molecules and cell growth in small cell lung cancer

  2013cites this paper
• An Overview of Important Genetic Aspects in Melanoma

  2013cites this paper
• BRN2 is a transcriptional repressor of CDH13 (T-cadherin) in melanoma cells

  2012cites this paper
• Modulation of Wnt/β-catenin signaling pathway by bioactive food components.

  2012cites this paper
• Phosphorylation of BRN2 Modulates Its Interaction with the Pax3 Promoter To Control Melanocyte Migration and Proliferation

  2012cites this paper
• A Phosphatidylinositol 3-Kinase–Pax3 Axis Regulates Brn-2 Expression in Melanoma

  2012cites this paper
• New perspectives on melanoma: The role of PAX3

  2011cites this paper
• The Role of Cellular Differentiation and Cell Fate in Malignant Melanoma

  2011cites this paper
• Inverse expression states of the BRN2 and MITF transcription factors in melanoma spheres and tumour xenografts regulate the NOTCH pathway

  2011influential citation
• A POU3F2-MITF-SHC4 Axis in Phenotype Switching of Melanoma Cells

  2011cites this paper
• Genome‐wide analysis of POU3F2/BRN2 promoter occupancy in human melanoma cells reveals Kitl as a novel regulated target gene

  2010cites this paper
• Transcriptional Control Of Neural Crest Development

  2010cites this paper
• Aus der Klinik und Poliklinik für Dermatologie und Allergologie der

  2009cites this paper
• Nestin and SOX9 and SOX10 transcription factors are coexpressed in melanoma

  2009cites this paper
• PPARgamma agonists attenuate proliferation and modulate Wnt/beta-catenin signalling in melanoma cells.

  2009cites this paper
• Expression and purification of human full-length N Oct-3, a transcription factor involved in melanoma growth.

  2009cites this paper
• Analysis of cultured human melanocytes based on polymorphisms within the SLC45A2/MATP, SLC24A5/NCKX5, and OCA2/P loci.

  2009cites this paper
• SOX9 and SOX10 but not BRN2 are required for nestin expression in human melanoma cells.

  2009cites this paper
• Estudo de fatores genéticos envolvidos no melanoma cutâneo

  2009cites this paper
• Pigmentation PAX‐ways: the role of Pax3 in melanogenesis, melanocyte stem cell maintenance, and disease

  2008cites this paper
• Oncogenic BRAF Regulates Melanoma Proliferation through the Lineage Specific Factor MITF

  2008cites this paper
• Histologic and epidemiologic correlates of P-MAPK, Brn-2, pRb, p53, and p16 immunostaining in cutaneous melanomas

  2008cites this paper
• Direct Genotyping of Single Nucleotide Polymorphisms in Methyl Metabolism Genes Using Probe-Free High-Resolution Melting Analysis

  2008cites this paper
• Brn-2 represses microphthalmia-associated transcription factor expression and marks a distinct subpopulation of microphthalmia-associated transcription factor-negative melanoma cells.

  2008cites this paper
• Understanding Signaling Cascades in Melanoma †

  2008cites this paper
• The new melanoma: a novel model for disease progression

  2008cites this paper
• POU domain transcription factors: BRN2 as a regulator of melanocytic growth and tumourigenesis

  2008influential citation
• Fine-tuning of intrinsic N-Oct-3 POU domain allostery by regulatory DNA targets

  2007cites this paper
• [Malignant melanoma and the role of the paradoxal protein Microphthalmia transcription factor].

  2007cites this paper
• Differential effects of phosphorylation on DNA binding properties of N Oct-3 are dictated by protein/DNA complex structures.

  2007cites this paper
• Osteonectin downregulates E‐cadherin, induces Osteopontin and Focal adhesion kinase activity stimulating an invasive melanoma phenotype

  2007cites this paper
• The WNT/Beta-catenin pathway in melanoma.

  2006cites this paper
• Melanoma Development and Pigment Cell Transformation

  2006cites this paper
• Genetic variants in epigenetic genes and breast cancer risk.

  2006cites this paper
• Altered Signal Transduction in Melanoma

  2006cites this paper
• BRN2 in melanocytic cell development, differentiation, and transformation

  2006cites this paper
• Molecular Cancer Rb Induces a Proliferative Arrest and Curtails Brn-2 Expression in Retinoblastoma Cells

  2006cites this paper
• Co-expression of SOX9 and SOX10 during melanocytic differentiation in vitro.

  2005cites this paper
• Identification of the ‘NORE’ (N-Oct-3 responsive element), a novel structural motif and composite element

  2005cites this paper
• Determination of transcription factors and their possible roles in the regulation of Pax3 gene expression in the mouse B16 F1 melanoma cell line

  2005cites this paper
• The transcription network regulating melanocyte development and melanoma.

  2004cites this paper
• The Brn-2 Transcription Factor Links Activated BRAF to Melanoma Proliferation

  2004cites this paper
• Brn-2 Expression Controls Melanoma Proliferation and Is Directly Regulated by β-Catenin

  2004cites this paper
• Characteristic patterns of N Oct-3 binding to a set of neuronal promoters.

  2004cites this paper
• Human melanoblasts in culture: expression of BRN2 and synergistic regulation by fibroblast growth factor-2, stem cell factor, and endothelin-3.

  2003influential citation
• Expression of Developmentally Regulated Transcription Factors in Merkel Cell Carcinoma

  2003cites this paper
• MLANA/MART1 and SILV/PMEL17/GP100 are transcriptionally regulated by MITF in melanocytes and melanoma.

  2003influential citation
• Altered HOX Gene Expression in Human Skin and Breast Cancer Cells

  2003cites this paper
• The Merkel Cell

  2003cites this paper
• The melanocyte-specific isoform of the microphthalmia transcription factor affects the phenotype of human melanoma.

  2002cites this paper
• Differentiation therapy of human cancer: basic science and clinical applications.

  2001cites this paper
• Constitutive Expression of MHC Class II Genes in Melanoma Cell Lines Results from the Transcription of Class II Transactivator Abnormally Initiated from Its B Cell-Specific Promoter1

  2001cites this paper
• Bacterial and yeast chaperones reduce both aggregate formation and cell death in mammalian cell models of Huntington's disease.

  2000cites this paper
• Domains of Brn-2 that mediate homodimerization and interaction with general and melanocytic transcription factors.

  2000cites this paper
• Characterization of a promoter for the human glial cell line-derived neurotrophic factor gene.

  1999cites this paper
• Critical targets of protein kinase C in differentiation of tumour cells.

  1999cites this paper
• Mutation in an Essential Housekeeping Gene Lymphocytes on a Melanoma Result from a Single Point Two Antigens Recognized by Autologous Cytolytic T Updated

  1999cites this paper
• Two antigens recognized by autologous cytolytic T lymphocytes on a melanoma result from a single point mutation in an essential housekeeping gene.

  1999cites this paper
• POU domain genes are differentially expressed in the early stages after lineage commitment of the PNS-derived stem cell line, RT4-AC.

  1998cites this paper
• Redox regulation of Brn-2/N-Oct-3 POU domain DNA binding activity and proteolytic formation of N-Oct-5 during melanoma cell nuclear extraction

  1998cites this paper
• Highly Cooperative Homodimerization Is a Conserved Property of Neural POU Proteins*

  1998cites this paper
• Isolation, characterisation, and chromosomal localisation of the mouse and human vasoactive intestinal peptide receptor type 2 genes

  1997cites this paper
• POU domain transcription factors in embryonic development

  1997cites this paper
• Linkage analysis of familial melanoma and chromosome 6 in 14 Australian kindreds

  1997cites this paper
• The control of gene expression in melanocytes and melanomas.

  1996cites this paper
• Adriamycin-induced DNA Adducts Inhibit the DNA Interactions of Transcription Factors and RNA Polymerase (*)

  1996cites this paper
• msg1, a novel melanocyte-specific gene, encodes a nuclear protein and is associated with pigmentation.

  1996cites this paper
• The POU domain transcription factor Brn-2: elevated expression in malignant melanoma and regulation of melanocyte-specific gene expression.

  1995cites this paper